Pages

Subscribe:

Friday, September 7, 2012

BRIEF-Peregrine Pharma surges after non-small cell lung cancer trial results

NEW YORK, Sept 7 (Reuters) - Peregrine Pharmaceuticals Inc
:
* Pharma surges 56.4 percent to $4.80 after non-small
cell lung cancer trial results

oregon mesothelioma attorney

No comments:

Post a Comment

Make Wood Pellet Biomass